AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

AbCellera Biologics Inc.

$12.27 +$8.84 (+257.73%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$13.08
Day Range
$11.75$12.91
Year Range
$2.75$15.02
Market Cap
3.98B
AVG Volume
6.53M
Trailing/Forward PE
-22.72/-
PEG ratio
-2.02
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ABCL Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q266.17M
26 Q179.21M
25 Q475.13M
25 Q335.32M
25 Q232.88M
25 Q123.11M
24 Q428.83M
24 Q332.96M
24 Q233.05M
24 Q135.79M
Net Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ABCL Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-164.66M
26 Q1-143.96M
25 Q4-146.41M
25 Q3-171.68M
25 Q2-165.66M
25 Q1-167.87M
24 Q4-162.86M
24 Q3-175.8M
24 Q2-153.3M
24 Q1-146.9M
Operating Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ABCL Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-225.16M
26 Q1-211.96M
25 Q4-217.1M
25 Q3-261.28M
25 Q2-278.66M
25 Q1-322.53M
24 Q4-314.77M
24 Q3-308.06M
24 Q2-269.29M
24 Q1-227.23M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ABCL

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 9 Nov 2026.

AbCellera Biologics Inc.
ABCL
Stockpicker

Video analysis: ABCL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ABCL

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.